Cancer vaccines in the clinic
Bioengineering & Translational Medicine · 2024-01 · 9 (1)
DOI: 10.1002/btm2.10588 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 27.10.2023. Verfasst von Morgan E Janes und 4 weiteren Autor:innen. Beteiligte Einrichtung: John A. Paulson School of Engineering & Applied Sciences, Harvard University Cambridge Massachusetts USA. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Harvard University, National Science Foundation.
Abstract (Originalsprache)
Vaccines are an important tool in the rapidly evolving repertoire of immunotherapies in oncology. Although cancer vaccines have been investigated for over 30 years, very few have achieved meaningful clinical success. However, recent advances in areas such antigen identification, formulation development and manufacturing, combination therapy regimens, and indication and patient selection hold promise to reinvigorate the field. Here, we provide a timely update on the clinical status of cancer vaccines. We identify and critically analyze 360 active trials of cancer vaccines according to delivery vehicle, antigen type, indication, and other metrics, as well as highlight eight globally approved products. Finally, we discuss current limitations and future applications for clinical translation of cancer vaccines.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- John A. Paulson School of Engineering & Applied Sciences, Harvard University Cambridge Massachusetts USA.
- Wyss Institute for Biologically Inspired Engineering Boston Massachusetts USA.
- Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology Cambridge Massachusetts USA.
- Department of Pharmaceutical Sciences College of Pharmacy, University of Illinois Chicago Chicago Illinois USA.
- University of Illinois Cancer Center Chicago Illinois USA.
ORCID-Profile: Zongmin Zhao, Samir Mitragotri
Förderung
- Harvard University
- National Science Foundation
Zitieren
APA
Janes, M. E., Gottlieb, A. P., Park, K. S., Zhao, Z., & Mitragotri, S. (2024). Cancer vaccines in the clinic. Bioengineering & Translational Medicine, 9(1). https://doi.org/10.1002/btm2.10588
Vancouver
Janes ME, Gottlieb AP, Park KS, Zhao Z, Mitragotri S. Cancer vaccines in the clinic. Bioengineering & Translational Medicine. 2024;9(1). doi:10.1002/btm2.10588
BibTeX
@article{Janes2024,
author = {Janes, Morgan E and Gottlieb, Alexander P and Park, Kyung Soo and Zhao, Zongmin and Mitragotri, Samir},
title = {Cancer vaccines in the clinic},
journal = {Bioengineering & Translational Medicine},
year = {2024},
volume = {9},
number = {1},
doi = {10.1002/btm2.10588}
}
EUVIMED